Nice showing by Chris and Brad yesterday, definitely got ROI in terms of exposure. It seems like the merger talk comes and goes, people generally are saying that mergers will pick up the second half of this year so I guess we’ll see. Once this gets going, It’s gonna be interesting. It’s a minnow of an acquisition to a suitor like Merck; it would put them squarely in front of the right customers for their planned pending launch, plus potentially be able to really grow this asset with the horsepower they would bring to the table.